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Improving the identification of cancer in young people: A scoping review. 
 
Abstract 180/200 
Introduction: The challenges of achieving timely cancer diagnosis in adolescents and young adults are 
recognised. However, contributing factors and associated clinical and psychosocial outcomes are 
poorly understood.  
Areas covered: We present a scoping review of existing evidence into time intervals to diagnosis and 
potential mechanisms influencing the identification of cancer symptoms and impact on a timely 
diagnosis. Charting data using Walters ‘pathways to treatment’ we summarise the diagnostic 
pathway into four interval categories: appraisal, help-seeking, diagnostic, and pre-treatment, and 
illustrate where evidence exists and where unanswered questions remain.  
Expert commentary: Whilst the research base has expanded over the last decade in cancer care 
there continues to be limited research that reveals the complexity of the timeliness of diagnosis in 
this population. There are unique issues facing this age group in terms of rarity of cancer, complexity 
of symptoms and problems with healthcare system access that create a constellation of challenges. 
We offer explanations for diagnostic difficulties in this age group, and explain how, with the limited 
available evidence, we are still seeking solutions to what is a uniquely complex problem. 
 
Key Words: Teenagers; adolescents; young adults; timeliness of a cancer diagnosis; pathways to 
treatment; scoping review
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1. Introduction 
A diagnosis of cancer is a significant life event for anyone, but perhaps more so for adolescents and 
young adults (AYA’s), as they are at a particularly vulnerable developmental stage [1]. The adjunct of 
a potentially life threatening diagnosis with the normative developmental tasks of adolescence can 
have an adverse impact on AYA’s physical and emotional wellbeing: this potential impact can be 
profound. The symptoms of cancer, superimposed on the anxiety of the period leading up to a 
diagnosis, can evoke psychological distress, uncertainty and fear in young people. Many describe 
their diagnostic experience with a sense of loss, anger, and frustration [2]. However, with a definitive 
diagnosis the process of renegotiating a new sense of identity and place in the world can begin. 
Young people, using social media, have also described trying to make the best of their situation, 
finding ways to overcome negative emotions and an urgency to return to normal as soon as they 
could, even if this was to a ‘new normal’ [3]. 
 
Improving both the experience and outcomes of a cancer diagnosis through earlier intervention has 
become the focus of national policy in the United Kingdom [UK] [4-6], in the United States [US] [7], as 
well for international AYA clinical partnerships [8]. Specific to the UK context there are two relevant 
health policy initiatives. First, the ‘two-week wait’, introduced in 2000, whereby anyone with a 
suspected cancer would be referred to a specialist within fourteen days [9]. Second, the National 
Awareness and Early Diagnosis Initiative [10], introduced in 2008, that continues to spearhead an 
increased focus on the importance of earlier diagnosis and its potential association with reduced 
morbidity and mortality in some cancers [10]. It is recognized, however, that precisely quantifying the 
relationship between the time taken to diagnosis and survival is challenging but it is known that, for 
some cancers at least, a shorter time to diagnosis is associated with a poorer outcome [11]. Despite 
this, there is a general consensus that optimizing the time from symptom onset to a definitive cancer 
diagnosis is a worthwhile pursuit [5, 12-17]. Not least this is because strength of the patient voice 
across the cancer population suggests that ‘rapid and adequate referral’ is an important measure of 
quality [18], and subjective experience of high quality care [19]. Delayed and/or multiple referrals are 
associated with a greater chance of decreased confidence in either the patient’s General Practitioner 
(GP) or another referring clinician [20,21]. Patterns of referral, and the subsequent patient journey, 
have been studied in the UK with the most common route to diagnosis for older adults aged between 
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50 and 79 being the two week urgent GP referral for suspected cancer [22]. In contrast the most 
common route for those aged 15-24 is via non-two week wait GP referrals (26%), followed by 
emergency presentation at Accident and Emergency [A&E] Departments (24%). In this first report 
only 13% of AYA were diagnosed via the two-week wait initiative suggesting minimal impact from this 
earlier referral policy for this population [23]. However, the most recent National Cancer Intelligence 
Network data would suggest that while the most common routes to diagnosis are still via non-urgent 
GP referral (28%) and A&E admissions (26%), the proportion being diagnosed by urgent two-week 
referral has increased considerably to 22% reflecting a change in practice, and perhaps greater 
awareness of the unique needs, of this age group [24]. The association between A&E cancer 
diagnosis-related admissions and poorer outcomes has not been confirmed in AYA and insufficient 
data exists, however the nature of presenting symptoms for some young people’s cancers may mean 
that A&E will be their first point of entry into the healthcare system.  
 
The NAEDI campaign in the UK also includes a focus on improving help-seeking behaviours through 
screening, self-examination and the promotion of better cancer awareness [25-27]. The latest UK 
campaign ‘Be clear on cancer’ [28], stresses the link between early diagnosis, higher success of 
therapies and improved quality of life for patients. However, the relationship between greater 
awareness, better cancer-related knowledge, improved interpretation of symptoms, and the 
subsequent positive impact on timely access to health-care, and hence effective and timely therapies, 
is a complex mix, and these various factors are only beginning to be examined in the AYA population 
[29-30]. Hence there exists a continuing need to drive a national ambition to achieve earlier 
diagnosis. Indeed, this is one of the six strategic priorities from the UK Cancer Taskforce [31], being 
implemented through the ACE program: Accelerate, Coordinate, Evaluate [32], exploring innovative 
concepts in early diagnosis pathways. 
 
Much of the existing evidence regarding the time to diagnosis has been generated from research 
with adult cancers; limiting its generalisability to the AYA population. The existing evidence, 
therefore, provides little in the way of easily identifiable solutions to improve the timeliness of a 
definitive diagnosis for this population. Part of the explanation for this situation is related to deficits 
in the quality (as well as quantity) of published research which may be difficult to interpret through 
lack of precise definitions, variations on health systems or lack of reproducible methodologies [33-
Page 3 of 37
URL: https://mc.manuscriptcentral.com/erq   Email: mary.yianni@informa.com
Expert Review of Quality of Life in Cancer Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
4 
34]. However, increasing evidence, from a number of sources, is now emerging that may have 
greater specificity to younger people with cancer (Table 1). As a result, this ensures that the 
timeliness of a cancer diagnosis remains close to the top of the UK cancer policy agenda [35].  
 
Given this situation we sought to identify elements of the diagnostic pathway that have already been 
subjected to analysis. This is in order to contextualise the many factors across the diagnostic 
pathway, that may influence the practice and timeliness of achieving a cancer diagnosis in AYA 
groups in the UK, and elsewhere; as well as to inform the focus and direction for future 
interventional research.  
 
2. Methodology 
We undertook a scoping review of the relevant literature. Scoping studies aim to map rapidly the key 
concepts underpinning a research area and can be especially useful where an area is complex [36]. 
Such reviews typically do not assess the quality of included studies, but present an analytical 
reinterpretation of the literature to guide more focused lines of research inquiry [37]. We used the 
five stages originally described by Arksey and O’Malley [36], and the work by Levac [37] that aim to 
enhance this review methodology: Stage 1, identifying the research question; Stage 2, identifying 
relevant studies; Stage 3, study selection; Stage 4, charting the data; Stage 5, collating, summarizing 
and reporting the results. 
 
2.1 Research question  
What is the extent, range and nature of research that best describes what we know about the 
diagnostic pathway for adolescents and young adults (AYAs) with cancer?  
 
2.2 Identifying relevant studies 
Data were identified through searches of MEDLINE, PubMed, OVID and Psychlit, using the search 
terms "adolescent", “teenager”, “young adult”, "cancer", "diagnosis" and ‘’delay’’. Papers identified 
from the search were cross-referenced with cited sources within the retrieved papers so that any 
otherwise non-identified papers could be included. Relevant policy documents were also accessed by 
online review and hand searching.  
 
2.3 Study selection 
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Inclusion criteria: 
1. Peer-reviewed research exploring the diagnostic process, including delay. 
2. Published in English between 1990 and 2016. 
3. Reporting on adolescents and young adults, defined as those between 16 to 24 years in the 
UK.  
4. Reporting on child-AYA or adult-AYA in the same paper. 
Exclusion criteria: 
1. Reporting on adolescents or young adults, <16 years, >24 years. 
2. Reporting a single population of ‘adults’ or ‘child’ in a paper. 
 
Copies of the full articles were obtained for those studies that appeared to represent a ‘best fit’ with 
our research question.  
 
2.4 Charting the data 
One of the most influential models for describing pathways to a cancer diagnosis was proposed by 
Andersen et al in 1995 [38]. This original model describing ‘total patient delay’ has been summarised 
in three overall categories by Hansen et al 2008 [39]: patient delay, doctor delay, and system delay. 
Historically, patients and professionals have referred to ‘delay in diagnosis’ and ‘diagnostic delay’ 
however, there has been a move away from this terminology due to the negative connotations of 
‘delay’ which may impose guilt and regret from a patient perspective if they have delayed seeking 
help for a symptom which turned out to be cancer related; it might also imply some degree of blame 
or neglect on the healthcare professional. The revised model by Walter et al 2012 [40] reflects more 
acceptable parlance and importantly illustrates that the pathways to diagnosis are often not linear as 
patients may transverse back and forward along the pathway as diagnostic tests are verified or 
dismissed [41]. Four categories of the diagnostic process are described [40]: appraisal, help-seeking, 
diagnostic, and pre-treatment intervals. These categories of interval provided an analytical 
framework to use when charting our data (Figure 1). Walters model also cites a number of 
contributing factors which influence these intervals: patient factors (demographics, psychological, 
social, cultural, previous experience); disease factors (size, growth rate); and healthcare provider and 
system factors (access, healthcare policy and delivery). Considering each of these factors allowed us 
to deliberate these in the context of young people and demonstrate how some of the contributing 
factors are unique to this group.  This also assisted us in illustrating where evidence existed and 
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where unanswered questions remain. The framework was used to chart a narrative summary of 
information gained from each publication. Charting against this framework helped further in 
improving our understanding by building on existing knowledge that may be applicable in the real-
world context of policy and service development [42] Included therefore are additional publications 
outside of our search parameters that are thought to be relevant to illuminate the ‘whole story’ on 
timeless of achieving an accurate cancer diagnosis in this age group. 
 
2.5 Collating, summarizing and reporting results 
Electronic searches revealed a total of 340 articles, 297 were rejected and 43 full copies were 
retrieved for eligibility assessment. We included all papers at this stage, irrespective of the research 
methodology, and included editorials, letters, and research reports, if they dealt with cancer and 
diagnostic intervals in the AYA population. After rejection of a further 18, three additional papers 
identified through citations were also deemed eligible for inclusion giving a total of 28 papers for 
review (Figure 2).  
 
The majority of eligible publications included combined data on cancer diagnosis in children and 
AYAs, and only eight focused specifically on the AYA group as a single population. Table 1 summarizes 
the main characteristics of the final 28 publications: 19 retrospective and prospective studies on 
diagnostic intervals, five papers on adolescents’ knowledge, awareness and attitudes towards cancer, 
three systematic reviews and one editorial (n=28).  
 
3. Results 
Here we present a narrative summary of the results discussed within discrete headings as per the 
four intervals in the pathways to treatment (Figure 1).  
 
3.1 Appraisal interval 
This is defined as the time from awareness of a bodily change to perceiving the need to discuss 
symptoms with a healthcare professional, such as a GP, or to make contact with the acute health care 
system. Appraisal interval has been described in a number of helpful studies spanning child and early 
adolescent cancers [43-44] This body of research, mostly utilizing retrospective analysis of medical 
notes and cohort designs, suggests that age appears to be a significant factor [45-46] Those in their 
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teenage years are more likely to experience a longer interval from initial symptoms to reporting 
symptoms to healthcare professionals than younger children [46, 47-52]. There is little research as 
yet to underpin explanations of this longer interval in AYA, however in the context of Walters 
contributing mediators there are some identifiable and unique factors. 
 
Disease factors: symptom pattern 
One possible explanation for the effect of age on a timely cancer diagnosis is symptom pattern. 
Younger children may experience cancers with more identifiable signs at onset (such as an abdominal 
mass in Wilms’ tumour) than older children or AYAs. However, studies have reported a positive 
association between age and diagnostic interval still being present even after the type of cancer was 
controlled for [46, 53-54]. This would suggest that the effect of age on interval may, in part, be due to 
more than simply differences in tumour-specific characteristics [45]. Appreciating the importance of 
symptoms that lead to help-seeking behaviours, may lead to a better understanding of the time 
between symptom onset and diagnostic trajectory. The following risk factors have been identified in 
the literature to date: symptom recognition, psychological factors, socio-demographic influences and 
ethnicity [40]. 
 
Patient factors: cancer awareness 
The initial presentation of possible cancer symptoms, due to rarity and lack of specificity in this age 
group, has been associated with prolonged time intervals [47, 50, 55-56]. Public awareness of early 
warning signs of cancer has been identified as playing an important role in symptom recognition 
(although it has also been identified as a prompt for seeking medical help by the ‘worried well’) [55, 
57]. Two studies in the UK have shown that cancer awareness in adolescents is low [58-59]. In both 
studies adolescents did not know the most common cancer in the AYA age group, and there was also 
the belief that cancer was unrelated to age [28]. In a cross sectional study in the UK [29], teenagers 
recall of cancer signs was good for lump/swelling, but their recall of other cancer warning signs or 
symptoms was very poor (13.8% for both ‘unexplained pain’ and a ‘change in the appearance of a 
mole’, 6.5% for ‘weight loss’ and 1.3% for ‘a sore that does not heal’) and one in four young people 
could not name a sign or symptom of cancer. Moreover, studies from the UK, United States, Turkey 
and The Netherlands have shown that self-examination for signs of cancers found in AYAs is also poor 
[59-62]. For example, the number of young males knowing how to, or who have performed, testicular 
self-examination was low [59-61] as was female adolescents’ knowledge of breast self-examination 
Page 7 of 37
URL: https://mc.manuscriptcentral.com/erq   Email: mary.yianni@informa.com
Expert Review of Quality of Life in Cancer Care
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
8 
[62]. 
 
Health knowledge has been found to be a contributing factor in diagnostic processes and a lack of 
knowledge has been linked to AYA’s intentions to delay health care seeking, even when signs and 
symptoms are present. It has been shown that adolescents who have never heard of testicular self-
examination were more likely to report the intention of putting off health care seeking with 
symptoms of testicular cancer [63]. Conversely, three quarters of adolescents taking part in a Survey 
(Cancer Awareness Measure [CAM]) stated that they would seek help for a symptom they thought 
might be cancer within three days [29]. Hence, empowering AYAs for greater self-care and early 
detection of cancer are important and seem to be worthwhile pursuits [64]. It has been suggested 
that health education within schools should also reflect cancer topics including the importance of 
early recognition of possible signs and symptoms [58]. School environments provide fertile ground 
for public health campaigns, particularly when the materials used are age specific to aid relevance 
and retention [30].  
 
Patient factors: demographics and psychosocial 
Longer intervals from initial symptoms to the reporting of symptoms to healthcare professionals, 
when compared with younger children [44, 46, 47, 51], may be explained by a range of demographic 
and psychosocial factors. Young people’s strong sense of independence and sense of invincibility may 
lead to a decrease in parental influence over this age group as well as to an undervaluation of 
symptoms; hence AYAs may be more likely to delay attracting attention to themselves [64]. In-depth 
interviews about young people’s pre-diagnostic experiences has shown that they may normalize or 
wrongly attribute their symptoms to something other than cancer, and other people (such as 
parents, teachers, neighbours or co-workers) may play a significant role in prompting them to have 
troublesome symptoms investigated [65]. Gender-associated behavior expectations may also 
influence a longer appraisal interval, however findings have not been consistent, with one study 
reporting that males diagnosed with a medulloblastoma experienced a longer duration of symptoms 
than females [66]. Moreover, a powerful social desire to appear ‘normal’ and ‘independent’ often 
associated with adolescence may also contribute to a reluctance to trust adults – including the 
medical establishment [49]. Nevertheless, contrary to perceptions that AYAs may generally have less 
contact with health care services, Fern et al.’s study [67] found that this age group do indeed consult 
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with GPs with symptoms.  Thus young people do consult their GP, however this is generally for 
routine non-cancer reasons such as contraception and pregnancy and infection [67].  
 
Overall, research evidence into the appraisal interval shows that from first symptom to consultation 
with the healthcare system is not a straightforward process. Age may indeed have been associated 
with an increased time interval, but age alone is insufficient to ‘truly’ understand prolonged symptom 
appraisal. Attitudes, beliefs and social context clearly also influence the process of making a decision 
to seek help. Increasing cancer awareness may deserve to be an important national health policy 
imperative: as simply being able to talk about cancer is one determinant of medical help-seeking [68]. 
 
3.2 Help-seeking interval 
Patient factors: psychological  
This refers to the interval from perceiving a reason to share symptoms with a healthcare professional 
to the first consultation. Within the adult literature recent findings have shown cross country 
comparisons with adults putting off going to the doctor as they do not want to ‘waste the doctors 
time’. For young people emotional barriers to help-seeking were actually the most commonly 
endorsed behaviours by more than half of participants in one study of cancer awareness (‘worry 
about what the doctor might find’, ‘too embarrassed’, ‘too scared’, and ‘not feeling confident to talk 
about symptoms’), followed by service (e.g., ‘difficulty talking to the doctor’) and practical barriers 
(e.g., being ‘too busy’) [30]. Similar findings have been described with an Italian population of 
adolescents. They also described not wanting to alarm their parents, and avoided the need to have 
their body examined or touched by adopting a ‘wait and see approach’ [69]. A similar approach was 
also reported by Dixon-Woods et al [70]. In this study, parents did not want to appear ‘anxious’, 
‘overprotective’ or ‘neurotic’ by consulting a GP too often or too early. Thus most parents adopted a 
‘wait and see’ approach for mild symptoms e.g. viral symptoms, sore throat, or tiredness. General 
Practitioners also discussed fear as the single most important factor, both consulting and delaying, 
with a good professional/patient relationship being a prerequisite for patients’ concerns being taken 
seriously. Patients’ accounts of their experiences prior to their diagnosis also show the importance of 
this relationship. When young people were well known to the GP, action seemed to be taken more 
quickly; conversely the lack of relationship had a negative influence on AYA’s chances of been taken 
seriously [65]. Hence, the lack of routine care prior to any cancer symptoms, as well as any co-
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existing communication barriers, may have an impact on the relationship between patients and 
professionals and consequently on a timely diagnosis [49]. The differences described in barriers to 
help-seeking behaviour provides further evidence as to why studies carried out with adult 
populations cannot always be extrapolated across AYA’s and why they should be studied as a unique 
group.   
 
Patient factors: age and social 
Exchanging opinions with peers, and seeking information online may also represent early steps in 
seeking help that avoids the need to consult with healthcare professionals directly [69]. Adolescents 
in the 21st century rely on technology much more than their adult counterparts for communication, 
accessing information, and generally, living life (e.g., using social Web sites, texting, and messaging) 
[71]. Thus these avenues may offer other routes for health information that avoid the need to ask 
questions of professionals, or communicate their fears by providing privacy, ease of access and even 
a sense of community [72-73]. The unreliability of some Internet content however is a concern for 
many AYAs [74]. At the current time, there is a substantial knowledge gap in the Internet on the 
matter of cancer in our population [69]. 
Healthcare provider and system factors: access 
Access to medical care in some countries can also influence duration of the help seeking interval 
(e.g., in the US some young people are not covered by parents’ health insurance) [49, 75]. For others 
social services barriers, such as being on income support, or unemployed, and having personal/family 
stability have also been described in terms of inequalities that impact on the diagnostic pathway [76]. 
In some countries the primary physician for children and AYA is a pediatrician, not a GP, where 
familiarity with cancers that occur in this age group may reduce the time to diagnosis: both health 
care systems and geographical differences are factors also known to affect the symptom interval and 
patient delay [77].  
 
Overall, research into the help-seeking interval is limited. There is however much we can learn from 
adolescents as a population. We know that their health issues may be less closely monitored by their 
parents when compared to younger children, and we know they may be reluctant to talk openly 
about, and hence disclose, worrying symptoms that they may be experiencing. Lack of awareness 
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about health risks and their changing bodies, poor knowledge and limited experience of the 
healthcare system or how to access it, compounded by social and societal influences combine to 
impact negatively on help-seeking behaviours. Possible solutions, such as improving cancer 
awareness, are relatively inexpensive, as well as making more communication opportunities available 
so that AYA’s can find accurate information about worrying symptoms. 
 
3.3 Diagnostic interval 
This refers to the interval between first consultation with a healthcare provider and a cancer 
diagnosis being made. This may involve referrals for diagnostic tests or to specialist services.  
 
Healthcare provider and system factors: access, healthcare policy and delivery 
The type of healthcare professional contacted initially has been reported as having a direct impact on 
the length of this interval (44, 45, 46, 47, 77-80].  For example, longer intervals have been reported 
for those presenting to their GP compared to Accident & Emergency (A&E) departments. In Dang-Tan 
et al’s study [48] into children and adolescents with leukaemia and lymphomas in Canada, longer 
diagnostic intervals were found after referral to secondary care; patients first seen in a hospital 
emergency room also had a lower risk of delay than patients first seen by a GP. Presentation to A&E 
more commonly led to immediate X-rays than a GP consultation. It has been claimed that these 
increased intervals are not necessarily a reflection on GP’s actions (or inaction) but may exemplify 
the weaknesses within the process of referral from professional too professional [81]. Parents may 
try to speed up this process with the use of private medical services, accessing alternative medicine 
or by resorting to A&E departments for immediate advice after failed referrals from primary care 
[68]. 
 
The prompt referral for a suspected cancer symptom from primary care is known to be challenging 
for this age group [80]. Reasons are not entirely clear, but may include atypical presentations, 
suboptimal clinical reasoning or other healthcare factors [82]. Young people have reported repeated 
interactions with a range of health care professionals when seeking a diagnosis, including 
optometrists, dentists, pediatricians’ and other specialists [83]. A retrospective Italian study between 
September 2007 and March 2011, reported that the lag time between seeing a physician and being 
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referred to a specialist was longer for teenagers compared to children [84]. Young people have 
repeatedly reported multiple consultations prior to referral to a cancer specialist during an annual 
patient conference and this has recently gained further substantiation following analysis of the NHS 
Cancer Experience Survey [81,85].  Importantly young people aged 16-24 are twice as likely to have 
three or more consultations prior to referral compared to older adults. Approximately 40% of young 
people will consult three times or more prior to referral compared to 20% of older adults, thus 80% 
of older adults are referred on their first or second visit. Diagnosis via the A&E route has become 
associated with AYA experiencing repeated cycles of appraisal and help-seeking [86]. Referral 
guidelines for children and young people have been developed recently as a result, and are now in 
their second round of revisions (87-89). Evidence suggests from young people themselves however 
that there remain challenges when applying the guidance to AYA, or where there is a NICE qualifying 
symptom this may not always result in referral, and sometimes referrals were made but 
investigations did not occur [90]. Thus, the importance of the AYA cancer diagnostic interval 
continues to be recognised as inherently complex and an area worthy of further exploration [45, 46, 
85,90]. 
Disease factors: symptoms and types of cancer 
Quantitative studies using survey methods have shown that longer diagnostic intervals (rather than 
appraisal or help-seeking intervals) have been reported by AYAs [69]. This is also true in relation to 
cancers more often occurring in this age group, such as bone and soft tissue sarcoma and lymphomas 
[48]. Dang-Tan et al study [49] found that timeliness to diagnosis of bone cancers was influenced by 
longer diagnostic interval but shorter appraisal interval. Short appraisal interval and longer diagnostic 
interval and misdiagnoses have also been identified in a review of medical charts in South Africa [91].  
Many physical signs and symptoms of young people’s cancers such as fever, headache, fatigue, bone 
pain and weight loss may be attributed to more common problems such as, sporting injuries, stress 
and general fatigue [58, 79]. Pollock et al [46]. In a retrospective, multi-centred, study of children 
with a lymphoma or solid tumour, found longer lag time or symptom interval (time between 
presentation and diagnosis) in Hodgkin’s disease and bone sarcomas (particularly Ewing’s sarcoma) 
than in those with brain tumours or non-Hodgkin’s lymphomas - the shortest lag time was for those 
children with neuroblastoma. Even after adjustment for age in a multivariate analysis of covariance, 
tumour type continued to have a statistically significant association with interval [46]. Factors may 
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include the slow-growing nature of Hodgkin’s lymphoma and Ewing’s sarcoma; their peak incidence 
being in the second decade, together with an often longer diagnostic process compared to some 
other cancers [12]. In Dang-Tan et al.’s study [48], cancer subtype was associated with diagnostic 
interval - but not with patient appraisal - for lymphoma patients. Patients with non-Hodgkin’s 
lymphoma had longer delays as those with Hodgkin’s disease. In this particular case, the differences 
between disease symptoms and signs for these two different forms of lymphoma may have 
contributed to this difference. Goyal et al [44]. study found that the site of the tumour (axial vs. limb) 
affected diagnostic interval in that the same symptoms in the absence of an obvious ‘visible mass’ did 
not seem to alert the suspicion of the healthcare professional in the same way that limb-associated 
symptoms did. This is similar to other studies where more unusual symptoms (such as gait 
abnormalities, ataxia or abdominal masses) also had a shorter time interval [51].  
 
Healthcare provider and system factors: healthcare policy and delivery 
Although there has been less research about the in-depth experiences of healthcare professionals 
and why they may not suspect a cancer, it has been shown that several factors may impact on this 
situation. These include: perceptions of symptoms and the implications of the socio-economic status 
and age of the patient; past experiences with diagnosing cancer (it may be rare for GP to see AYA 
with cancer - a GP in the UK, for example, may be expected to see, on average, only one child under 
15 with cancer every 15 years [81] or only 7 to 8 new cases of cancer, in all age groups, per year); and 
structural issues such as lack of time, lack of team working, lack of consistency in seeing patients, 
poor follow-up mechanisms and missed communications between different settings. These may all 
be considered important and relevant to the reasons for diagnostic delay in AYAs [89]. 
 
Moreover, although there is no evidence at present that lack of knowledge or awareness about AYA 
cancer is related to increased healthcare professional time intervals, it has been suggested that 
training in AYA cancer diagnosis could be beneficial in improving the recognition of classic cancer 
symptoms [83]. However, many will present with what are described as symptoms that have low or 
very low positive predictive values; and are often non-specific and vague in nature. Thus the ‘alarm’ 
symptoms - such as pain or physical changes – [92] that may generate a risk assessment in adult 
cancer care [93], are not always present or reliable in this population [94]. Presenting with non-alert 
symptoms, as categorized in the NICE guidance [88], is known to increase the diagnostic interval [95]. 
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As part of a national audit of cancer diagnosis in primary care in the UK, 40% of young people who 
were identified attended the GP three times or more before being referred [96]. A significant event 
audit carried out under the aegis of NAEDI illustrated that GPs themselves spoke about the 
difficulties in engaging, and obtaining a diagnosis with this age group, and mentioned the perceived 
reluctance of some young people to seek advice. The importance of professional vigilance, effective 
communication and the appropriate management of unresolved symptoms have also been 
highlighted within the existing literature and remain relevant [96]. 
 
Young people themselves in in-depth interviews have also suggested that a wide variety of intervals 
to diagnosis are a recurring element of some young people’s cancer trajectory [65]. For instance, 
some have reported not being taken seriously, not having their concerns addressed and often feeling 
that healthcare professionals might not attribute their ongoing symptomatology to cancer [65]. These 
findings suggest that young people were often not investigated for cancer until after they had visited 
their doctor several times, or until they, or their parents, also started to think something more 
serious was wrong. Young adults have expressed the opinion that GPs should consider serious illness 
earlier, even if it seems unlikely [65]. 
  
The period prior to diagnosis is important in shaping the nature of adaptation and the subsequent 
reaction to the diagnosis itself [70]. Qualitative studies in childhood cancer focusing on parents’ recall 
of the diagnosis of cancer in their child [70, 97, 98], suggest that difficulties in reaching a diagnosis 
has the potential to cause friction in the GP/parent relationship [99]. This is particularly so when 
parents did not think their concerns had been listened to [97]. Similar findings have been reported 
with the AYA age group [65]. Perceptions about diagnostic intervals are clearly significant, with a 
considerable overlap in the time reported by parents who felt that the diagnosis was not timely, as 
compared to those who did {97]. Patient confidence is known to be a core element of the doctor-
patient relationship: and further research is needed to understand the impact the period prior to 
diagnosis has on this relationship in the long-term [99]. 
 
Overall, we would agree with Black et al (86 p13) that the pathway to receiving a cancer diagnosis in 
AYA’s may be both ‘prolonged and circuitous’. Where a GP route has not resulted in resolution, AYA 
may engage with other routes, such as A&E, where tests might be more rapidly forthcoming. NICE 
guidance [88], as it currently stands, might not assist with the nuances and differences in AYA’s as 
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they do not take full account of the many contributing factors (identified by Walters) that present as 
challenges to GPs and others. 
 
3.4 Pre-treatment interval 
This refers to the interval between a definite diagnosis being made and the initiation of cancer 
control treatment. This is the part of the cancer trajectory where there has been the least research. It 
has been recognized, and this paper has already demonstrated, that prompt diagnosis and referral 
for treatment in AYA can be challenging from a clinical perspective, due to the wide range of 
malignancies and the multiplicity of symptomatologies that may arise. Cancers in AYA can be 
classified into three main categories: those that typically arise as ‘late paediatric’ cancers such as 
Wilms’ tumour; those that are described as ‘early onset adult cancers’ such as melanoma; and those 
which have a peak incidence in this age group alone such as osteosarcoma [100]. The most common 
cancers in adults comprise only a small proportion of cancer diagnosed in AYA; nevertheless, cancer 
type has been associated with pre-treatment interval and lymphomas, bone tumours and soft tissue 
sarcomas.  which have a higher incidence in this age group, typically require molecular and other 
diagnostic tests before administering first treatment [47].  Papers have identified delays in the 
detailing of histological sub types [49, 91]; delays in both the referral to and correct reporting and 
communication from imaging [79, 104]; and delay in referrals to the correct specialist [65, 81, 101].  
 
Poor communication between services, poor reporting of results and the waiting for appointments 
was found to be particularly stressful for young people, especially after a diagnosis of cancer had 
been made [65]. In Klein-Gletink et al’s study [101] (where outcomes were compared between 
adolescents treated in adult-orientated and child cancer centres) the interval for referral of AYA to 
adult-orientated centres was found to be twice as long as those for childhood cancer centres.  
 
Whilst this may be the least researched phase of all across the cancer trajectory it remains important 
as negative psychosocial reactions may be expected following cancer delay, or where disease is much 
more advanced meaning that treatment is less likely to be curative [65]. It is also a phase where 
positive relations can be established that can support the young person going forward into cancer 
treatment. 
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These structural, organisational, resource and pathway related issues have generally been less 
researched across all age groups but certainly warrant wider scale attention and programmes of work 
in the future. 
 
4. Limitations of this review 
As this was a scoping review some papers may have been missed during the literature searching 
process. If a full systematic review had been undertaken more databases would have been searched 
and could have identified additional relevant studies. However, we suggest that the review captures 
the state of the art in this field of research, with the remaining areas for future research clearly 
identifiable.  
We were also well aware of the methodological limitations of some of the research in this field that 
have been well-documented [33,34]. Others have criticized research designs where information 
collected through pre-existing records and/or patient/parent recall may not always be reliable [34]. 
Identifying possible sources of diagnostic delay from the perspective of patients and healthcare 
providers is uniquely challenging due to symptom/disease complexities as well as the many steps 
involved in the diagnostic trajectory superimposed on complex health systems. An earlier review 
[102] emphasized the danger of attributing simplistic solutions to inherently complex phenomena. 
The studies included here share and reflect these limitations. Furthermore, difficulties are 
acknowledged in terms of the lack of research where the AYA age group have been studied as a 
discreet group. Most papers do not focus specifically on this specific age group meaning that some 
evidence has been drawn from studies of childhood cancer that included AYA in their populations in 
recognition of their contribution to the conclusions.  
 
5. Expert commentary 
Whilst the research base has expanded over the last decade in AYA cancer care there continues to be 
limited research that reveals the complexity of the timeliness of diagnosis in this population. There 
are unique issues facing this age group in terms of rarity of cancer, complexity of symptoms and 
problems with accessing the healthcare system that creates a constellation of challenges (Figure 3). 
Given this complexity our use of a methodological framework to structure charting and analysis of 
the literature has enabled a fuller description of the importance of the various interval factors to be 
understood and examined further. In terms of the particular needs of the AYA age group, this review 
has highlighted the importance of understanding the significance and range of factors such as 
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17 
attitudes to health care, the nature of cancer symptoms, information needs and the social reality of 
young people’s lives, that combine to impact negatively on timely help-seeking behaviour and 
eventual diagnosis. 
 
Given the relatively rare incidence of cancer in the AYA population, superimposed on the complexity 
of primary and secondary health care systems, it is perhaps not surprising that a prolonged diagnostic 
pathway may occur in this age group. The existing evidence points to a combination of ways to firstly 
theorise and understand, and then improve, the diagnostic experience for younger people facing 
cancer.  Here the evidence has been used to clarify what changes may be possible to modify in a 
positive way (such as greater AYA, parent, public and professional awareness; communication 
between services; and timely access to care) and to highlight others that remain problematic (such as 
vagueness of symptoms or health system failure). The threat of a cancer diagnosis or serious illness 
does not sit easily in the everyday world of AYAs. As a result, further research is needed to better 
understand how to improve outcomes by tackling the first two stages of symptom appraisal and help-
seeking by concentrating on assessing the need to seek professional help and motivation to attend 
the first appointment. 
 
The interval between the first consultation with a healthcare provider and a cancer diagnosis has 
often been seen as significant in the time to diagnosis. It may involve repeated visits before anything 
serious is suspected, and time being taken up for referral to diagnostic tests or to specialist services. 
Having key healthcare professionals respond, and allowing AYAs to have a voice and be heard, are 
key components to this stage of the AYA cancer trajectory. However, we currently have little 
empirical information about the impact of multiple consultations on young people. It must also be 
remembered that for many GPs it may be that clinical reasoning was appropriate as in many cases 
benign conditions were eliminated.  Indeed, the healthcare professional, structural, disease and 
symptom related factors that contribute to this time interval exemplify why the time to diagnosis 
may be complex and prolonged and further support the need for evidence-based solutions. Although 
there is less research in this area, and the prognostic implications of lengthened diagnostic time 
intervals are not always clear, the link between time intervals and an increase in psychological stress 
in AYA’s is apparent.  
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For instance, it is known that prolonged periods to diagnosis have been found to have a significant 
clinical impact in terms of raising levels of anxiety, uncertainty and coping in children [51, 98]. Gibson 
et al's [65] study pointed to the importance of young people feeling that they had a voice, and that 
their symptoms and worries and concerns were heard, and when they were not, a significant lack of 
trust and anger could develop. Tishelman and Sachs [103] found that after a process of constant 
negotiation between popular and professional judgements, an eventual diagnostic outcome provided 
the opportunity for a new framework of ‘normality’. Similar findings emerged from an interview 
study with AYA and nurses on the distressing and positive experiences of cancer. Over half responded 
that a definitive diagnosis was better than pre-diagnostic uncertainty, with hope becoming more 
realistic once the prognosis and treatments were explained [104]. 
 
Timeliness of a cancer diagnosis and the emotion it brings can thus have significant repercussions for 
coping during the diagnostic period, treatment and adaptation to life after treatment. As mentioned 
earlier there is very little research as yet for AYA in the pre-treatment phase, but after a diagnosis of 
cancer, this is something which should addressed in future research. In the UK, healthcare providers 
are assessed on the ability to provide cancer treatment within a certain time.  The current target 
waits between the date the hospital receives an urgent GP referral for suspected cancer and starting 
treatment; starting treatment no more than 31 days after the meeting at which AYA and a medical 
healthcare professional agree the treatment plan.  If patients are delayed in the pre-treatment phase 
it maybe to clarify precise details of tumour biology and pathology, making complex treatment plans 
or identifying clear treatment pathways. http://www.cancerresearchuk.org/about-cancer/cancers-in-
general/cancer-questions/waiting-times-for-tests-and-treatment-after-cancer-diagnosis#treat)   
Generally hospitals are meeting this target for most of their patients. Although as Klein-Gletink [101] 
state there are differences in this phase for AYA going to a children’s cancer centre as opposed an 
adult cancer centre. The reasons for this are unclear but may include lack of established care 
pathways, less specialist nature of care in general adult compared to children’s cancer together with 
the possibility of different diagnostic groups and diagnostic pathways in adult and children’s cancer 
centres.  
 
6. Five-year view  
Understanding the reasons that impact on a timely and accurate cancer diagnosis is important for all 
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age groups and, in this population, would benefit from further research focused on the perspectives 
of young people themselves, the healthcare professionals who care for them, and research into 
structural and organisational barriers for timely access, referral and diagnosis. Such evidence 
ultimately needs to be strengthened by considering the range of data needed, such as diagnostic 
timelines; symptom profiles and disease outcomes; professional perceptions and roles; and service, 
referral and communication barriers - within the context of current service or policy developments: 
in the UK and elsewhere. Complex and multi-factorial phenomena, such as the diagnostic process, 
are likely to require complex, multi-method, multi-perspective research approaches. With the 
subsequent development of appropriative interventions (Table 3) and changes in practice and policy, 
it may be possible that under-researched patient groups such as AYAs may achieve more timely 
diagnoses of cancer.  
 
In the meantime, we have to consider the pressures on health systems to process more demand, 
both in general practice and in hospital contexts, and AYA cancer care is only one of the multiple 
demands facing providers. Given this situation it is also important to contextualise what research will 
be needed to understand health systems as inherently complex and inter-connected, and where 
promoted values such as psychological adaptation to cancer, holism and patient safety must co-exist 
alongside concerns with service efficiency and cost-control. 
 
We suggest that the existing research is already highlighting the existence of a problem with AYA 
cancer diagnosis that needs to be addressed in a number of ways. Firstly, policy is needed, based on 
evidence, that will help enhance access to age appropriate information and support. Secondly, 
research should build on existing gaps and address the most pertinent questions that should be 
asked to improve the diagnostic experience. Reviews such as this can help in this regard and more 
research is now being supported; such as the Lymphoma Research Foundation in the United States 
which has an AYA funding initiative.  
 
Finally, the views of young people themselves should remain at the heart of accounts of where 
systems can be seen to encourage, or deter, them from seeking help.  The third sector has a key role 
to play here and much opportunity exists for charities and lobby groups to influence awareness of 
the signs, symptoms and diagnostic trajectory for cancer across all age groups: for example, in the UK 
an online educational resource has recently been developed through the collaboration of two UK 
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charities http://elearning.rcgp.org.uk/course/info.php?id=232 [105]. For the AYA population this 
review has highlighted the growing evidence that can be used to understand their needs in being 
diagnosed as quickly as possible in order to effect the best possible outcome. 
 
Key issues 
• Non-specific presenting symptoms, low awareness, system failures and rarity of cancer in this 
population impacts on the timeliness of achieving a cancer diagnosis.  
• Effective communication, with an emphasis on diagnostic uncertainty in discussions between 
healthcare professionals and AYA, is essential so that AYA fully understand the decisions that 
are made. 
• Adolescents and young adults must be encouraged to return to their GP if symptoms escalate: 
re-appraisal of symptoms and help-seeking is not linear. 
• The prognostic implications of a possible time-lag remains unclear.  
• Lack of AYA awareness about themselves and their bodies, their community and health care 
systems impacts on elements of the diagnostic pathway. 
• The support needs of parents and those closest to these young people is important as they 
also face the challenge of a cancer diagnosis. 
• Untimely diagnosis affects the overall patient experience negatively, and may not place the 
AYA in the best position in terms of future relationships with primary or specialist cancer 
services.  
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Figure 1. Model of pathways to treatment 
 
From Walter et al 2012  
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Figure 2. Scoping studies 
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Table 3 Examples of possible future interventional research 
 
Time interval Recommendation 
Appraisal Target public awareness campaigns. 
Increase health knowledge and health education in schools. 
Raise awareness of the more common cancers that occur in this 
age group. 
Inform healthcare professionals and health systems of common 
delays. 
 
Help-seeking Increase the public’s confidence that cancer is a survivable 
disease. 
Increase the quality of information available on the Internet. 
Develop and test strategies that help young people make the 
most of encounters with primary care. 
Improve access to primary care - getting appointments, length of 
appointments and consistency in healthcare professional on each 
occasion.  
 
Diagnostic Increase education and training in primary care. 
Involve young people in the design and review of existing 
services.  
Develop strategies to in estigate earlier persistent symptoms of 
common illnesses.  
Patient as expert needs to be emphasised. 
Ensure rare cancers are managed in centres of excellence. 
 
Pre-treatment Explore pre-diagnostic experiences to establish trusting 
relationships with professionals and services. 
Offer choice of treatment location where possible. 
Encourage awareness and services that allow young people to 
remain in control once a diagnosis is made. 
Explore communication pathways and blocks between settings 
and departments of care. 
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